This review examines how different biological layers, known as multi-omics, might help explain recurrent pregnancy loss. The review looks at existing data from various studies, including genomics, proteomics, and microbiome analyses, to find patterns in how pregnancy loss occurs.
The findings show several links. Researchers found associations between chromosomal abnormalities and early embryonic failure. They also identified unusual methylation patterns and changes in how certain immune cells, such as macrophages and T cells, communicate with each other. Additionally, the data suggests that immune and metabolic signatures may be linked to issues with how the placenta develops.
It is important to note that this is a review of existing literature, not a single new clinical trial. The current evidence is limited by small study sizes, a lack of long-term follow-up, and the need for more large-scale testing across different centers. Because these studies show associations rather than direct causes, the results are not yet ready to change standard medical practice.
While these findings are an important step toward identifying specific subtypes of pregnancy loss, more research is needed to confirm these patterns and turn them into reliable tools for patient care.
